- Standard Blood Glucose Meters (SBGM)
- Continuous Glucose Monitors (CGM)
Diabetic Monitoring Devices Market size was valued at USD 514.2 million in 2023 and is poised to grow at a CAGR of 4.0% from 2024-2030. The market is driven mainly by the increasing prevalence of diabetes, sophisticated technology, and the growing use of insulin delivery devices. Blood glucose monitoring system devices are used to measure glucose levels in an individual's blood. These systems play a vital role in patients suffering from type 1 and type 2 diabetes. According to its estimates, IDF reports a very high and increasing global prevalence of diabetes, in 2021, around 10.5% of the adult population of the age group 20-79 years was reported to be suffering from diabetes.
That would amount to approximately 537 million adults in the world, and by 2045 IDF projected that there will be 783 million adults affected with diabetes, which is almost every 1 in 8 adults. This is driven by factors such as urbanization, aging of the population, decreased levels of physical activity, and rising overweight and obesity rates. This changing prevalence ratio coincides with a growing demand for effective management tools such as diabetic monitoring devices. However, constraints such as high costs of devices, inadequate reimbursement policies, lack of awareness in developing countries, and the invasive nature of some devices. Growth in wearable technology, expansion in emerging markets, telemedicine and remote monitoring, and AI and data analytics integration are the opportunities that were constants of the diabetic monitoring devices market can overcome. Some current trends in the diabetic monitoring devices market are the increasing use of continuous glucose monitors (CGMs), artificial pancreas development, integration with mobile health apps, and a shift toward non-invasive monitoring.
Study Period
2024-2030Base Year
2023CAGR
4.0%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Technological changes have driven the diabetic monitoring devices market. Results are a more accurate, convenient method of maintaining diabetes through better equipment. Continuous glucose monitoring systems are one of the biggest developments made in diabetes care. Apart from the traditional finger-pricking, CGM systems involve the use of sensors placed under the skin that measure blood glucose continuously. That means that patients can take live data from this and make better decisions regarding their dosing of insulin and changes in lifestyle. The CGM system can also provide trend reports, which help healthcare providers recognize the different patterns occurring within blood sugar levels and adjust treatment plans accordingly. Other medical advances include smartwatches or fitness trackers that increasingly integrate diabetic monitoring functionality, allowing patients to monitor blood sugar, activity, and other parameters from a single device. Artificial intelligence can analyze CGM data and use it to predict future blood glucose levels to assist proactive management and reduce the risk of hypoglycemia or hyperglycemia.
By Syringe Type
By Disease
Geography
The diabetic monitoring devices market size was valued at USD 514.2 million in 2023 and is poised to grow at a CAGR of 4.0% from 2024-2030.
• Rising Prevalence of Diabetes • Sophisticated Technology • The Growing Use of Insulin Delivery Devices
• Growth In Wearable Technology • Expansion In Emerging Markets • Telemedicine And Remote Monitoring • AI And Data Analytics Integration
The diabetic monitoring devices market has a growth rate of 4.0% during the forecast period
Market research report segments covered are product type, disease, and region.
Europe is the dominating region in the diabetic monitoring devices market.
Asia-Pacific is the fastest region in the diabetic monitoring devices market.
1.Executive Summary |
2.Global Diabetic Monitoring Devices Market Introduction |
2.1.Global Diabetic Monitoring Devices Market - Taxonomy |
2.2.Global Diabetic Monitoring Devices Market - Definitions |
2.2.1.Syringe Type |
2.2.2.Disease |
2.2.3.Region |
3.Global Diabetic Monitoring Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Diabetic Monitoring Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Diabetic Monitoring Devices Market By Syringe Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Standard Blood Glucose Meters (SBGM) |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Continuous Glucose Monitors (CGM) |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Diabetic Monitoring Devices Market By Disease, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Type 1 Diabetes |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Type 2 Diabetes |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Diabetic Monitoring Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Diabetic Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Syringe Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Standard Blood Glucose Meters (SBGM) |
8.1.2.Continuous Glucose Monitors (CGM) |
8.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Type 1 Diabetes |
8.2.2.Type 2 Diabetes |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Diabetic Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Syringe Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Standard Blood Glucose Meters (SBGM) |
9.1.2.Continuous Glucose Monitors (CGM) |
9.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Type 1 Diabetes |
9.2.2.Type 2 Diabetes |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Diabetic Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Syringe Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Standard Blood Glucose Meters (SBGM) |
10.1.2.Continuous Glucose Monitors (CGM) |
10.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Type 1 Diabetes |
10.2.2.Type 2 Diabetes |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Diabetic Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Syringe Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Standard Blood Glucose Meters (SBGM) |
11.1.2.Continuous Glucose Monitors (CGM) |
11.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Type 1 Diabetes |
11.2.2.Type 2 Diabetes |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Diabetic Monitoring Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Syringe Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Standard Blood Glucose Meters (SBGM) |
12.1.2.Continuous Glucose Monitors (CGM) |
12.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Type 1 Diabetes |
12.2.2.Type 2 Diabetes |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Hoffmann-La Roche Ltd (Switzerland) |
13.2.2.Terumo Corporation (Japan) |
13.2.3.Dexcom, Inc. (U.S.) |
13.2.4.Ascensia Diabetes Care Holdings AG (Switzerland) |
13.2.5.Medtronic (Ireland) |
13.2.6.LifeScan IP Holdings, LLC (U.S.) |
13.2.7.Senseonics (U.S.) |
13.2.8.Abbott (U.S.) |
13.2.9.Braun SE (Germany) |
14. Research Methodology |
15. Appendix and Abbreviations |